Rheumatologist Steven Mendelsohn, MD, agreed to pay $549,554 to resolve allegations under the False Claims Act, according to a Jan. 28 news release from the U.S. Attorney’s Office.
What happened?
- In 2019, Dr. Mendelsohn allegedly submitted reimbursement claims to Medicare for intravenous immunosuppressive arthritis drugs that were not approved by the FDA for marketing and distribution in the U.S.
- The drugs were allegedly purchased from unauthorized distributors and intended for foreign markets.
- The settlement resolves civil allegations only.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
